Trial Profile
European Active Surveillance Study of LCS12
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 09 Jan 2024
Price :
$35
*
At a glance
- Drugs Levonorgestrel (Primary)
- Indications Pregnancy
- Focus Therapeutic Use
- Acronyms EURAS_LCS12
- 05 Jan 2024 Status changed from recruiting to active, no longer recruiting.
- 23 Feb 2022 Planned number of patients changed from 70000 to 83000.
- 23 Feb 2022 Planned End Date changed from 1 Jun 2024 to 1 Dec 2026.